Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT for High-Risk Localized Prostate Cancer
NCT02296229Active, not recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2014
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Biochemical Progression-Free Survival at 3 years, Incidence of Genitourinary and Gastrointestinal Toxicity at 4 months and 1 more. Started Jan 2014; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02296229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296229.